An antisense drug in development at GSK has shown further activity against hepatitis B virus (HBV) in a mid-stage trial, setting up a phase 3 assessment next year to see if it could offer a ...
A digital therapeutic (DTx) that aims to treat negative symptoms of schizophrenia, like apathy and social withdrawal, has hit the target in a phase 3 trial. The smartphone-based CT-155 app, ...
From L.A. and Detroit to Geneva and Tokyo, MotorTrend covers every major auto show in the world as it happens. Although some shows are changing, others are ending, and new ones emerging, MotorTrend ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback